EUVIMEDEUVIMED entdecken
Crossref

Cerebrospinal fluid sTREM2 and PGRN in the early diagnosis and progression monitoring of Alzheimer's disease: A longitudinal study

Xifen Gong iD, Muhammad Uzair Khalid iD, Jinyun Long iD, Ziqi Zhou iD, Jiayu Li iD, Kemeng Bai iD, Xiaofeng Li iD, Alzheimer’s Disease Neuroimaging Initiative

Journal of Alzheimer’s Disease · 18.11.2026

DOI: 10.1177/13872877261507326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 18.11.2026. Verfasst von Xifen Gong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Die Arbeit nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD) features amyloid-β (Aβ) deposition and tau pathology, with microglial dysfunction and neuroinflammation increasingly implicated. Soluble triggering receptor expressed on myeloid cells-2 (sTREM2) and progranulin (PGRN) regulate microglial function and lysosomal homeostasis, but their dynamics across the AD continuum remain unclear.

Objective

To investigate cerebrospinal fluid (CSF) sTREM2 and PGRN in the early diagnosis and progression monitoring of AD, and their associations with Aβ pathology and other biomarkers.

Methods

Data were from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Based on CSF Aβ 42 and Clinical Dementia Rating (CDR) scores, subjects were categorized into Aβ−CN (n = 196), Aβ+CN (n = 101), Aβ+MCI (n = 378), and Aβ+AD (n = 96). Baseline demographics, neuropsychological assessments, imaging indices, and CSF biomarkers were compared. Spearman correlation, ROC curve analysis, and linear mixed-effects models (n = 255) were used.

Results

Baseline CSF sTREM2 was lower in Aβ+CN than Aβ−CN. PGRN was lower in Aβ+CN and Aβ+MCI than Aβ−CN. Over 2 years, sTREM2 increased most in Aβ+MCI and moderately in Aβ+CN, while PGRN declined in Aβ−CN, Aβ+MCI, and Aβ+AD. Both biomarkers correlated with CSF tau and p-tau in Aβ+ individuals.

Conclusions

Baseline CSF sTREM2 and PGRN have limited cross-sectional diagnostic value for AD. However, their longitudinal trajectories raise the possibility that they may reflect the microglia-lysosome axis. Combined biomarker strategies and multi-targeted therapeutic interventions warrant further investigation.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseasePGRNbiomarkerlongitudinal studysTREM2

Autor:innen und Institutionen

  • Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Geriatric Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Xifen Gong, Muhammad Uzair Khalid, Jinyun Long, Ziqi Zhou, Jiayu Li, Kemeng Bai, Xiaofeng Li

Zitieren

APA

Gong, X., Khalid, M. U., Long, J., Zhou, Z., Li, J., Bai, K., Li, X., & Alzheimer’s Disease Neuroimaging Initiative (2026). Cerebrospinal fluid sTREM2 and PGRN in the early diagnosis and progression monitoring of Alzheimer's disease: A longitudinal study. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261507326

Vancouver

Gong X, Khalid MU, Long J, Zhou Z, Li J, Bai K, et al. Cerebrospinal fluid sTREM2 and PGRN in the early diagnosis and progression monitoring of Alzheimer's disease: A longitudinal study. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261507326

BibTeX
@article{Gong2026,
  author = {Gong, Xifen and Khalid, Muhammad Uzair and Long, Jinyun and Zhou, Ziqi and Li, Jiayu and Bai, Kemeng and Li, Xiaofeng and Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Neuroimaging Initiative},
  title = {Cerebrospinal fluid sTREM2 and PGRN in the early diagnosis and progression monitoring of Alzheimer's disease: A longitudinal study},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877261507326}
}
Kostenlos starten →